EP-2098: Use of a bladder minimum contour for prostate treatment planning to increase comfort and efficiency  by Evans, C. et al.
ESTRO 35 2016                                                                                                                                                    S987 
________________________________________________________________________________ 
evaluation was performed according to RTOG 
recommendation for IMRT. Patients were placed in two main 
categories: no anticoagulants and/or antiaggregants use 
category during RT and anticoagulants and/or antiaggregants 
one. Rectal toxicity was evaluated using the Common 
Toxicity Criteria Adverse Effect (CTCAE v. 4.03) All patients 
had assumed the anticoagulant and/or antiaggregant therapy 
before radiation therapy, during treatment as well as during 
the follow up. 
 
Results: 20 of the 73 patients treated with anticoagulant 
and/or antiaggregant therapy, presented rectal bleeding; 
while in the group of patients not taking anticoagulants 
and/or antiaggregants this even occurred in 10 patients of 
114 (p<0.001). Of the 20 patients who have received 
anticoagulant and/or antiaggregant agent who presented 
rectal bleeding, 8 developed G1 toxicity, 10 had G2 toxicity 
and 2 patients had G3 toxicity. Of the 10 patients who did 
not receive anticoagulant and antiaggregant therapy and 
presented rectal bleeding, 5 patients had G1 toxicity, 4 
present G2 toxicity and G3 toxicity only 1 patient. 
 
Conclusion: The results of our study found that patients 
taking anticoagulant and/or antiaggregants therapy 
undergoing curative radiotherapy for prostate 
adenocarcinoma have a higher risk of developing rectal 
bleeding. 
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Purpose or Objective: Stereotactic radiotherapy of liver 
metastases is challenging: breathing motion, and the 
flexibility of the abdominal organs, in particular remaining 
liver, may be large. This may render a priori imaging for 
position verification virtually useless. Hence, "decision to 
treat" may be difficult and stressful.  
Abdominal compression may be used to reduce movement 
and flexibility, but maximum compression is highly 
uncomfortable and probably intolerable for patients during 
the entire session (20-30 min). Our institution has chosen to 
limit compression so that patients can endure it easily during 
the entire session. This study investigates whether this type 
of abdominal compression is effective. 
 
Material and Methods: In short, a diagnostic 2 phase CT scan 
was used to locate tumor positions. Belt pressure and 
marking position (Orfit Industries), were reproduced for each 
treatment fraction. Each fraction, cone beam CTs (CBCT) 
were recorded before and immediately afterwards. Scans 
were matched offline, using deformable image registration 
(Varian Smart Adapt V13), resulting in “CBCT liver contours”. 
These were checked and adjusted, if necessary.  
Each CBCT liver contour was compared to original CT contour 
using absolute volume, center of mass shift (CMS) and dice 
coefficient (DC). To assess effectiveness of compression, data 
were averaged for each of the three computed parameters. 
 
Results: Until this date, a total of 6 patients were treated 
using this technique. All 6 tolerated the applied abdominal 
compression easily during the sessions. Therapists, trained in 
>> 100 brain or lung stereotactic treatments, reported no 
exceptional difficulties in fixation, CBCT, and matching.  
Data from 4 patients, and a total of 24 CBCTs, were eligible 
for analyses. Liver CBCT volumes appeared to be very similar 
to CT contours: the average is only 18 cc less, with a 
maximum of 116 cc. The average CMS in X, Y, Z are 0.14cm 
(max 0.41cm), 0.05cm (max 0.33cm) and 0cm (max 0.23cm), 
respectively. Average DC is 0.94, with a range of [0.89 0.99].  
 
Conclusion: Difference in volume, center of mass, and even 
shape are well within the range of standard uncertainties in 
stereotactic abdominal radiotherapy. This corroborates with 
the reported feasibility by therapists treating these patients.  
In short, the patient comfortable setting of the compression-
belt is reproducible and safe to correctly deliver the dose in 
stereotactic radiotherapy of the liver.  
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Purpose or Objective: Prostate cancer patients often find it 
difficult to maintain a full bladder throughout the course of 
their radiotherapy treatment. These bladder filling problems 
can result in patients being taken out of the treatment room 
in order to increase bladder filling, leading to treatment 
delays. The aim of this study was to provide a range of 
acceptable bladder sizes without compromising the bladder 
dose constraints. 
Material and Methods: An audit was carried out with ten 
patients who attended for IMRT radiotherapy planning for 
prostate cancer. A minimum bladder volume (bladder min) in 
each patient was defined by cropping the planning CT (pCT) 
bladder volume to around 150cc. This new volume was then 
used in addition to the pCT bladder volume in the IMRT plan 
optimisation to fulfil the bladder dose constraints. The 
patients had their bladder volume assessed prior to 
treatment using a standard CBCT imaging protocol. 
Retrospective dose calculations were undertaken using the 
daily CBCT images, and bladder doses were plotted against 
bladder volume to demonstrate that dose constraints were 
still being met at the reduced bladder volume. The tolerance 
doses used are taken from the CHHiP trial protocol. 
 
Results: The bladder min contour is used by the treatment 
radiographers as a visual guide on the CBCT scan taken 
before each treatment in order to assess whether the 
patient’s bladder is an acceptable size to continue with 
treatment without compromising bladder tolerance doses. 
The volume of the bladder min contour is adjusted to meet 
the constraints for each individual patient as necessary 
The need for patients to be taken out of the treatment room 
to re-fill the bladder has been reduced and this has resulted 
in better workflow on the treatment floor. The use of the 
bladder min contour for prostate IMRT treatment planning is 
now standard practice in our clinic. 
 
Conclusion: The use of the bladder min contour has improved 
patient comfort without compromising the therapeutic ratio 
and has aided the radiographers in online review of 
treatment images. 
The implementation of the above has led to a reduction in 
treatment delays due to the bladder volume obtained at 
planning CT not being maintained throughout treatment. This 
has improved the clinic workflow. Patient discomfort is kept 
to a minimum and repeat CBCT scans have been reduced. 
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Purpose or Objective: The aim of the study was an analysis 
of an influence of type and intensity of pts anxiety on pts 
repositioning during planning and delivery of RT to the pelvic 
area in relation to pts gender, immobilization device, and 
